Mablink Bioscience Raises €4M in Seed Funding

01 May, 2021

Mablink Bioscience Raises €4M in Seed Funding
Photo by Brendan Church on Unsplash

– Mablink Bioscience is a Lyon, France-based company developing antibody-drug conjugates (ADC).
– The company raised €4M in a seed financing round.
Elaia Partners led the round with participation from Pertinence Invest 2 (Sofimac Innovation advised by Mérieux Equity Partners), Sham Innovation Santé (advised by Turenne Capital), Fondation Fournier-Majoie, Simba Santé (Angelor) and Crédit Agricole Création.
– The new investment will be used to move forward its ADC pipeline.

Biotechnology Western Europe
Crunchbase icon

Content report

The following text will be sent to our editors: